209 related articles for article (PubMed ID: 18414880)
1. Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions.
Waxman EA; Duda JE; Giasson BI
Acta Neuropathol; 2008 Jul; 116(1):37-46. PubMed ID: 18414880
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
[TBL] [Abstract][Full Text] [Related]
3. Production of a monoclonal antibody, against human α-synuclein, in a subpopulation of C57BL/6J mice, presenting a deletion of the α-synuclein locus.
Mougenot AL; Bétemps D; Hogeveen KN; Kovacs GG; Chouaf-Lakhdar L; Milhavet O; Lehmann S; Legastelois S; Pin JJ; Baron TG
J Neurosci Methods; 2010 Oct; 192(2):268-76. PubMed ID: 20709102
[TBL] [Abstract][Full Text] [Related]
4. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
[TBL] [Abstract][Full Text] [Related]
5. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.
Emmer KL; Waxman EA; Covy JP; Giasson BI
J Biol Chem; 2011 Oct; 286(40):35104-18. PubMed ID: 21846727
[TBL] [Abstract][Full Text] [Related]
6. Leucine-rich repeat kinase 2 expression leads to aggresome formation that is not associated with alpha-synuclein inclusions.
Waxman EA; Covy JP; Bukh I; Li X; Dawson TM; Giasson BI
J Neuropathol Exp Neurol; 2009 Jul; 68(7):785-96. PubMed ID: 19535993
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of phospho-Ser129 α-synuclein monoclonal antibodies.
Delic V; Chandra S; Abdelmotilib H; Maltbie T; Wang S; Kem D; Scott HJ; Underwood RN; Liu Z; Volpicelli-Daley LA; West AB
J Comp Neurol; 2018 Aug; 526(12):1978-1990. PubMed ID: 29888794
[TBL] [Abstract][Full Text] [Related]
8. Fine epitope mapping of monoclonal antibodies specific to human alpha-synuclein.
Choi JY; Park HJ; Seong YM; Choi EY; Min BR; Rhim H
Neurosci Lett; 2006 Apr 10-17; 397(1-2):53-8. PubMed ID: 16380207
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation.
Fagerqvist T; Lindström V; Nordström E; Lord A; Tucker SM; Su X; Sahlin C; Kasrayan A; Andersson J; Welander H; Näsström T; Holmquist M; Schell H; Kahle PJ; Kalimo H; Möller C; Gellerfors P; Lannfelt L; Bergström J; Ingelsson M
J Neurochem; 2013 Jul; 126(1):131-44. PubMed ID: 23363402
[TBL] [Abstract][Full Text] [Related]
10. Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.
Spencer B; Valera E; Rockenstein E; Overk C; Mante M; Adame A; Zago W; Seubert P; Barbour R; Schenk D; Games D; Rissman RA; Masliah E
Acta Neuropathol Commun; 2017 Jan; 5(1):7. PubMed ID: 28086964
[TBL] [Abstract][Full Text] [Related]
11. Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration.
Tsika E; Moysidou M; Guo J; Cushman M; Gannon P; Sandaltzopoulos R; Giasson BI; Krainc D; Ischiropoulos H; Mazzulli JR
J Neurosci; 2010 Mar; 30(9):3409-18. PubMed ID: 20203200
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy.
Duda JE; Giasson BI; Gur TL; Montine TJ; Robertson D; Biaggioni I; Hurtig HI; Stern MB; Gollomp SM; Grossman M; Lee VM; Trojanowski JQ
J Neuropathol Exp Neurol; 2000 Sep; 59(9):830-41. PubMed ID: 11005264
[TBL] [Abstract][Full Text] [Related]
13. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody.
Yu S; Li X; Liu G; Han J; Zhang C; Li Y; Xu S; Liu C; Gao Y; Yang H; Uéda K; Chan P
Neuroscience; 2007 Mar; 145(2):539-55. PubMed ID: 17275196
[TBL] [Abstract][Full Text] [Related]
14. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against alpha-synuclein: tools and therapies.
Vaikath NN; Hmila I; Gupta V; Erskine D; Ingelsson M; El-Agnaf OMA
J Neurochem; 2019 Sep; 150(5):612-625. PubMed ID: 31055836
[TBL] [Abstract][Full Text] [Related]
16. Synphilin in normal human brains and in synucleinopathies: studies with new antibodies.
Murray IJ; Medford MA; Guan HP; Rueter SM; Trojanowski JQ; Lee VM
Acta Neuropathol; 2003 Feb; 105(2):177-84. PubMed ID: 12536229
[TBL] [Abstract][Full Text] [Related]
17. Studies of protein aggregation in A53T α-synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice.
Emmer KL; Covy JP; Giasson BI
Neurosci Lett; 2012 Jan; 507(2):137-42. PubMed ID: 22188655
[TBL] [Abstract][Full Text] [Related]
18. Generation and Characterization of Novel Monoclonal Antibodies Targeting p62/sequestosome-1 Across Human Neurodegenerative Diseases.
Trejo-Lopez JA; Sorrentino ZA; Riffe CJ; Prokop S; Dickson DW; Yachnis AT; Giasson BI
J Neuropathol Exp Neurol; 2020 Apr; 79(4):407-418. PubMed ID: 32106300
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.
Takahashi M; Ko LW; Kulathingal J; Jiang P; Sevlever D; Yen SH
Eur J Neurosci; 2007 Aug; 26(4):863-74. PubMed ID: 17714183
[TBL] [Abstract][Full Text] [Related]
20. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.
Uryu K; Richter-Landsberg C; Welch W; Sun E; Goldbaum O; Norris EH; Pham CT; Yazawa I; Hilburger K; Micsenyi M; Giasson BI; Bonini NM; Lee VM; Trojanowski JQ
Am J Pathol; 2006 Mar; 168(3):947-61. PubMed ID: 16507910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
